Jump to content

Organ rejection

From Surgopaedia

Hyperacute

[edit | edit source]
  • Minutes to days
  • Occurs due to high level pre-formed anti blood group or anti-HLA antibodies binding to endothelium of the graft (antibody-mediated reaction). Initiates a cascade of events culminating in vascular thrombosis and ischaemic necrosis of the graft.
  • Severe, untreatable, thrombotic reaction
  • Very rarely seen in modern times due to screening
  • Assessed by screening serum against a panel of regional donors
    • Non-sensitised patient = 0%
    • Sensitized = 100% and will need desensitization therapy
  • Near-universal graft loss, can try plasmapheresis and Ig infusion if diagnosis is made early
  • Preventable with typing, AB screening and cross-match

Acute

[edit | edit source]
  • Defined as an acute deterioration in allograft function with characteristic pathological findings
  • Diagnose with biopsy
  • Usually occurs five days (up to 10 days) after transplant
  • Either ABMR or T-cell mediated or both
  • Prevented by suppressing T cells
  • Management
    • Cell-mediated: pulse corticosteroids

Chronic

[edit | edit source]
  • Long-term fibrotic process related to accumulation of T-cells and macrophages
  • Indolent/repetitive ABMR or TCMR or non-immune insults

Approach to suspected rejection

[edit | edit source]
  • Organise a biopsy
    • Banff criteria on biopsy helps to diagnose, and will tell you whether it's T-cell or ABMR